Ross W. Stephens
Impact in
- Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research
Papers in
-
- Protease and Inhibitor Mechanisms 69
- Hematology 35
- Blood Coagulation and Thrombosis Mechanisms 31
- Co-authors
- Antti Vaheri (22 shared papers)Keld Danø (13 shared papers)J Pöllänen (8 shared papers)Nils Brünner (17 shared papers)Hans Jørgen Nielsen (12 shared papers)Hannele Tapiovaara (17 shared papers)Gunilla Høyer‐Hansen (9 shared papers)Eija Salonen (5 shared papers)
In The Last Decade
Ross W. Stephens
103 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 3.0k
- Immunology and Allergy 923
- Hematology 1.4k
- Oncology 1.1k
- Genetics 301
Countries citing papers authored by Ross W. Stephens
This map shows the geographic impact of Ross W. Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross W. Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross W. Stephens more than expected).
Fields of papers citing papers by Ross W. Stephens
This network shows the impact of papers produced by Ross W. Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross W. Stephens. The network helps show where Ross W. Stephens may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross W. Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 298 | |
| 2 | 1991 | 263 | |
| 3 | 1999 | 249 | |
| 4 | 1999 | 213 | |
| 5 | 1989 | 166 | |
| 6 | The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. | 1998 | 156 |
| 7 | 1981 | 132 | |
| 8 | High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. | 2000 | 132 |
| 9 | 1999 | 129 | |
| 10 | ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. | 1997 | 129 |
| 11 | 1999 | 115 | |
| 12 | 1997 | 112 | |
| 13 | Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. | 2002 | 112 |
| 14 | Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer. | 2002 | 100 |
| 15 | 2000 | 94 | |
| 16 | 1993 | 93 | |
| 17 | 1982 | 92 | |
| 18 | 1992 | 87 | |
| 19 | 1983 | 81 | |
| 20 | 1993 | 79 |
About Ross W. Stephens
Ross W. Stephens is a scholar working on Cancer Research, Hematology, Oncology, Immunology and Allergy and Molecular Biology, having authored 103 papers that have together received 4.8k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (69 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers), Cell Adhesion Molecules Research (27 papers), Peptidase Inhibition and Analysis (26 papers), Osteoarthritis Treatment and Mechanisms (8 papers), Blood properties and coagulation (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Proteoglycans and glycosaminoglycans research (6 papers). The work is most often cited by research in Cancer Research (3.0k citations), Immunology and Allergy (923 citations), Hematology (1.4k citations), Oncology (1.1k citations) and Genetics (301 citations). Ross W. Stephens has collaborated with scholars based in Finland, Australia and Denmark. Frequent co-authors include Antti Vaheri, Keld Danø, J Pöllänen, Nils Brünner, Hans Jørgen Nielsen, Hannele Tapiovaara, Gunilla Høyer‐Hansen, Eija Salonen, Ebbe Rønne and Niels Behrendt. Their work appears in journals such as Blood, European Journal of Biochemistry, Thrombosis Research, International Journal of Cancer and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.